Rivals Challenge Nintedanib In India

Glenmark And Sun Launch Generic Versions Of Boehringer's Cyendiv

 
• By Anju Ghangurde

Glenmark and Sun Pharma introduce nintedanib generics in India at a fraction of the innovator product’s price, vying for a share of the IPF market where pirfenidone currently holds sway.

Lungs
Indian Competition Arrives For Boehringer's Nintedanib • Source: Shutterstock

More from Products

More from Generics Bulletin